Literature DB >> 10761724

Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment.

I R Caldas1, R Correa-Oliveira, E Colosimo, O S Carvalho, C L Massara, D G Colley, G Gazzinelli.   

Abstract

Cellular and humoral immune responses to Schistosoma mansoni antigen preparations were evaluated in individuals presumed to be susceptible or resistant to reinfection after chemotherapeutic cure. A consistent proliferative increase in the response to soluble egg antigen (SEA) was observed post-treatment in both the susceptible and resistant groups. However, this change was not related to resistance. Isotype studies showed that IgM antibody levels to soluble worm antigen preparation (SWAP) and cercariae antigens were significantly higher in the resistant group than in the susceptible group. Post-treatment, an increase in IgE anti-SWAP and anti-schistosomular tegument (STEG) responses and a decrease in IgG4 anti-SEA and anti-STEG responses were observed in the resistant group. These finding are similar to those we have reported previously for a putative resistant group termed endemic normals, and are compatible with immunologic studies in different endemic areas. Together, these findings indicate that even on the population level, high IgE specificities coupled with low IgG4 specificities correlate well with documented resistance to reinfection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761724     DOI: 10.4269/ajtmh.2000.62.57

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

1.  Factors associated with resistance to Schistosoma mansoni infection in an endemic area of Bahia, Brazil.

Authors:  Ricardo R Oliveira; Joanemile P Figueiredo; Luciana S Cardoso; Rafael L Jabar; Robson P Souza; Martin T Wells; Edgar M Carvalho; Daniel W Fitzgerald; Kathleen C Barnes; Maria Ilma Araújo; Marshall J Glesby
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 2.  Vaccines to combat the neglected tropical diseases.

Authors:  Jeffrey M Bethony; Rhea N Cole; Xiaoti Guo; Shaden Kamhawi; Marshall W Lightowlers; Alex Loukas; William Petri; Steven Reed; Jesus G Valenzuela; Peter J Hotez
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

Authors:  Carla L Black; Erick M O Muok; Pauline N M Mwinzi; Jennifer M Carter; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

4.  Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees.

Authors:  M Eberl; J A Langermans; P A Frost; R A Vervenne; G J van Dam; A M Deelder; A W Thomas; P S Coulson; R A Wilson
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 5.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

6.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

7.  Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections.

Authors:  Angela Pinot de Moira; Frances M Jones; Shona Wilson; Edridah Tukahebwa; Colin M Fitzsimmons; Joseph K Mwatha; Jeffrey M Bethony; Narcis B Kabatereine; David W Dunne
Journal:  Infect Immun       Date:  2012-10-15       Impact factor: 3.441

8.  HTLV-1 modifies the clinical and immunological response to schistosomiasis.

Authors:  A F Porto; S B Santos; L Alcantara; J B Guerreiro; J Passos; T Gonzalez; F Neva; D Gonzalez; J L Ho; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

9.  Schistosoma mansoni infection in a rural area of the Jequitinhonha Valley, Minas Gerais, Brazil: analysis of exposure risk.

Authors:  Wesley Rodrigues Pereira; Helmut Kloos; Sara B Crawford; Jorge Gustavo Velásquez-Melendez; Leonardo Ferreira Matoso; Ricardo Toshio Fujiwara; Guilherme Grossi Lopes Cançado; Philip T Loverde; Rodrigo Correa-Oliveira; Andrea Gazzinelli
Journal:  Acta Trop       Date:  2009-09-16       Impact factor: 3.112

10.  Development of a Streptococcus gordonii vaccine strain expressing Schistosoma japonicum Sj-F1 and evaluation of using this strain for intranasal immunization in mice.

Authors:  Linqian Wang; Wei Liu; Ming Yang; Dan Peng; Liyu Chen
Journal:  Parasitol Res       Date:  2013-02-13       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.